KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Biomarin Pharmaceutical (BMRN) Loans and Notes Receivables: 2014-2015

  • Biomarin Pharmaceutical's Loans and Notes Receivables was N/A to $3.3 million in Q1 2015 from the same period last year, while for Mar 2015 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $46.9 million for FY2014, which is N/A change from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Loans and Notes Receivables stood at $3.3 million for Q1 2015, which was down 92.92% from $46.9 million recorded in Q4 2014.
  • Over the past 5 years, Biomarin Pharmaceutical's Loans and Notes Receivables peaked at $46.9 million during Q4 2014, and registered a low of $3.3 million during Q1 2015.
  • For the 2-year period, Biomarin Pharmaceutical's Loans and Notes Receivables averaged around $25.1 million, with its median value being $25.1 million (2014).